MDV To Release DPC Hospital Analysis Tool Aimed At Pharmaceutical Companies
This article was originally published in PharmAsia News
Medical Data Vision announced July 19 it will launch the MDV Analyzer, an analysis tool for accumulated clinical data from Japan's DPC (Diagnostic Procedure Combination) hospitals, on August 1.
You may also be interested in...
Asking whether FDA’s decision to allow emergency use of two old anti-malarial drugs was ‘political’ misses the point. The issue already was political, and FDA’s action may well be the best way to keep some measure of federal control on supplies of a drug with important other uses.
Guidelines for health care providers could help prevent shortages as demand for possible treatments surge, groups say. Stakeholders also argue “Buy America” executive order would hamper drug access.
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.